Greater Manchester based M&A Pharmachem staff say company failed to consult over redundancy process
A number of employees affected by the collapse of paracetamol and opiate manufacturer, M&A Pharmachem Limited are looking to pursue legal action against the company over claims the redundancy process wasn’t properly managed.
Based in Greater Manchester, with the manufacturing plant in Westhoughton near Bolton, M&A Pharmaceuticals made the shock announcement of its collapse on the 27th of January.
Reports suggest that the company failed to secure fresh investment after administrators had previously been called in, now, it has also been reported that eighty-four jobs are confirmed to have been lost.
Aticus Law says it has now been contacted by former employees who claim to have not been properly consulted over the redundancy process.
Aticus is now looking at the claims that the company failed to properly consult with staff about the job losses, with a view to pursuing legal action against them over the redundancy process was managed.
If successful, those involved in the challenge will be entitled to claim a Protective Award which is up to eight weeks’ worth of pay in compensation, with a cap of 544 per week.
Mohammed Balal of Aticus Law today urged others who had been affected by the collapse of M&A Pharmachem Limited to ensure their job title was included in the legal action, and by checking whether they are eligible to make a claim.
He said: “Regrettably, the...
A Sheffield councillor who came under fire for allegedly sharing a video promoting stem cell treatment for autism says the claims are "false". It is understood that Mustafa Ahmed, Green Councillor...